Open access

Study on Schistosomiasis mansoni and Comorbidity with Hepatitis B and C Virus Infection

Written By

Maria José Conceição and José Rodrigues Coura

Submitted: 08 May 2012 Published: 16 January 2013

DOI: 10.5772/55510

From the Edited Volume

Parasitic Diseases - Schistosomiasis

Edited by Rashika El Ridi

Chapter metrics overview

2,142 Chapter Downloads

View Full Metrics

1. Introduction

1.1. Comorbidity of S. mansoni infection and hepatitis B

In Brazil, despite decreases in the prevalence rates of schistosomiasis and in the frequency of severe forms, the targets for transmission control have not been reached. This should be taken to be a warning sign indicating that schistosomiasis must not be neglected in this country (Conceição & Coura 2012). It is also important to emphasize that co-infections such as the hepatitis B and C viruses play a role.

One of the few studies involving comorbidity with hepatitis B was conducted by Serufo et al. (1998). Two areas with schistosomiasis infection in Minas Gerais were correlated: one endemic and the other, a controlled non-endemic area, where it was shown that schistosomiasis did not change the course of hepatitis B. This had previously been emphasized by Andrade (1965) and Prince (1970), in studies on patients in different geographical regions.

Lyra et al. (1976) compared cases of hepatosplenic schistosomiasis (HSS) and control cases of the hepatointestinal form of the disease, including cases with a variety of illnesses. They found that the patients with HSS were carriers for HBsAg more frequently than the other groups were. Bassily et al. (1979, 1983) detected hepatitis B surface antigen in cases of hepatosplenic schistosomiasis. Pereira et al. (1994) did not find any significant difference in the frequency of these markers for hepatitis B between patients with the hepatointestinal form of schistosomiasis, the hepatosplenic form and controls. Conceição et al. (1998) evaluated the prognosis for individuals infected with S. mansoni and carriers of hepatitis B virus, among patients attended at the Teaching Hospital of the Federal University of Rio de Janeiro, Brazil. Nonsignificant predominance of HBsAg, anti-HBsAg and anti-HBc was detected among patients with the hepatosplenic form of schistosomiasis, who presented greater severity of clinical evolution, with a higher frequency of hematemesis and/or melena. In addition, development of macronodular cirrhosis was observed, with worse prognosis than for patients with the toxemic and hepatointestinal forms. However, Serufo (2000) considered that this kind of association was a fallacy.

Al-Shamiri et al. (2011) determined the disease prevalence and its relationship with hepatitis B and C viruses among 1484 school children aged between 5 and 16 years in five areas endemic for S. mansoni and S. haematobium. The overall prevalence was 20.76% for S. mansoni and 7.41% for S. haematobium. There was a correlation between S. haematobium and hepatitis B, but no association between S. mansoni infection and the hepatitis B and C viruses.

1.2. Association between S. mansoni infection and hepatitis C

In Egypt, HCV together with schistosomal parasite infection is the biggest risk factor for chronic liver disease. In most Egyptian patients, HCV genotype 4 is highly prevalent (Halim et al. 1999).

Kamal et al. (2000a) showed that patients with concomitant HCV and schistosomiasis were characterized by more advanced liver disease, higher HCV RNA titers, higher incidence of cirrhosis and hepatocellular carcinoma, and higher incidence of liver-related morbidity and mortality. Kamal et al. (2000b) concluded that patients with chronic hepatitis C and schistosomiasis co-infection responded poorly to interferon therapy and had higher relapse rates than among patients solely infected with chronic HCV.

However, some authors like Gad et al. (2001) and Kamel et al. (2002), in Egypt, mentioned that there appeared to be no epidemiological association between hepatic schistosomiasis and infection by the hepatitis C virus. Also in Egypt, Madwar et al. (1989) evaluated the hepatosplenic forms of the disease and did not show any correlation with serological indicators for hepatitis.

Lambertucci et al. (2005) emphasized that the studies on comorbidity of schistosomiasis and viral hepatitis lacked representative samples of inhabitants and control groups. They concluded that the evolution to chronic hepatitis and hepatic cirrhosis was related to the natural history of hepatitis.

Conceição et al. (2008) presented previous results from a study developed in Itaobim, a rural area of Minas Gerais, Brazil, with the aim of identifying the clinical repercussions of S. mansoni infection associated with hepatitis due to the B and C viruses. There was no statistical difference in the viral hepatitis B and C rates among S. mansoni infected patients, in comparison with a control group without positive parasitological examinations. From an investigation in the rural area of Jequitinhonha Valley, in Minas Gerais, Conceição et al. (2009) did not find any positive association between serological indicators for hepatitis B or C and severe clinical forms of Manson’s schistosomiasis.

The comorbidities that affect the course and response to anti-hepatitis C therapy include schistosomiasis, iron overload, alcohol abuse and excessive smoking. These co-infections negatively affect the course and outcome of liver disease, often reducing the chance of achieving a sustained virological response with PEGylated interferon and ribavirin treatments. Patients with chronic hepatitis C (CHC) infection and concomitant schistosomiasis respond poorly to IFN therapy and have higher relapse rates than among patients with HCV infection only (El-Zayadi 2009). There was no interaction between S. mansoni infection or disease and the prevalence or severity of hepatitis C in surveys that were conducted among 2038 Egyptians and 2120 Kenyans (El-Zayad 2009).


2. Research methods

The research methods used for preparing this chapter were based on articles written by our group and by other authors in the literature on the topic of Epidemiology of Schistosomiasis in Brazil, which were published in journals and books in Brazil and worldwide, and in MSc and PhD theses that are available through the internet, in the Oswaldo Cruz Foundation (Fiocruz) libraries, and in the School of Medicine of the Federal University of Rio de Janeiro (UFRJ). Reference was made to protocols and records used in clinical studies and in endemic areas, among the inhabitants, with clinical specifications and socioeconomic conditions. This work also used statistical analysis methods to evaluate whether the results obtained presented significant differences.


3. Conclusions

  • Most authors have not found any positive association between serological indicators for hepatitis B or C and the severe clinical forms of schistosomiasis mansoni;

  • Comorbidities such as infections due to the hepatitis B and C viruses may worsen the prognosis for the clinical evolution of hepatosplenic schistosomiasis.


  1. 1. Al-shamiriA. HAl-tajM. AAhmedA. S2011Prevalence and co-infections of schistosomiasis/hepatitis B and C viruses among school children in endemic areas in Taiz, Yemen. Asian Pacific Journal of Tropical Medicine 454048
  2. 2. AndradeZ1965Hepatic Schistosomiasis: morphological aspects. In H Popper, F Schaffner (eds), Progress in Liver Diseases, Grune & Stratton, New York. 228242
  3. 3. Barbosa FAS 1966Morbidade da esquistossomose. Rev Bras Malariol D Trop 8353357
  4. 4. BassilySDunnM. AFaridZKilpatrickM. EEl-MasryA. GKamelI. AEl-AlamyM. EMurphyB. L1983Chronic hepatitis B in patients with schistosomiasis mansoni. J Trop Med Hyg 866771
  5. 5. BassilySFaridZHighashiG. LKamelI. AE. L-M. a. s. r. y A. GWattenRH 1979Chronic hepatitis B antigenemia in patients with hepatosplenic schistosomiasis. J Trop Med Hyg 82248251
  6. 6. BlantonR. ESalamE. AKariukiH. CMagakPSilvaL. KMuchiriE. MThiongoFAbdel-meghidI. EButterworthA. EReisM. GOumaJ. H2002Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease. J Infect Dis. 1851116449
  7. 7. ChieffiP. P1992Interrelationship between Schistosomiasis and concomitant diseases. Mem Inst Oswaldo Cruz 87291296
  8. 8. ConceiçãoM. JArgentoC. AChagas VLA, Takiya CM, Moura DC, Silva SCF. S. mansoni Patients Infected with Hepatitis B. 1998Mem Inst Oswaldo Cruz, 93(Suppl. I): 255258
  9. 9. ConceiçãoM. JCouraJ. R2012Epidemiology of Schistosomiasis in Brazil. In: IN: Rokni MB. Schistosomiasis. 1a. ed. Ed. In Tech. Cap. 9. 183192Available at
  10. 10. ConceiçãoM. JOliveira MLA, Silva MLP, Silva IM, Borges-Pereira J. 2005Correlation of Viral Hepatitits A, B, C, D in Patients Infected with Schistosoma mansoni in a rural area from Capitão Andrade, Rio Doce Valley, Minas Gerais, Brazil. Abstracts X International Symposium on Schistosomiasis, Belo Horizonte, Minas Gerais, Brazil. 25-28 September 134
  11. 11. ConceiçãoM. JSilvaI. MYoshida CFT, Carlôto AE, Melo EV, Lemos EA, Miguel JC, Euzébio JEG, Pires L. 2008Prevalence of Serological Assays for Viral Hepatitis B and C in Inhabitants from Itaobim, an Endemic Area of Schistosomiasis mansoni- in Jequitinhonha Valley, Minas Gerais, Brazil. Abstracts XI International Symposium on Schistosomiasis, Salvador-Bahia, Brazil. 20-22 August 161
  12. 12. CoutinhoA1979Fatores relacionados com o desenvolvimento das formas clínicas da esquistossomose mansônica. Rev Assoc Med Bras 25185188
  13. 13. CoutinhoADomingues ALC 1988Esquistossomose mansoni. In R Danni, LP Castro (eds), Gastroenterologia Clínica, 2nd ed., Ed. Guanabara Koogan, Rio de Janeiro, 13621386
  14. 14. El-ZayadiA2009Hepatitis C comorbidities affecting the course and response to therapy. World J. Gastroenterol. 1549934999
  15. 15. GadATanakaEOriiKRokuharaANoomanZSerwahA. HShoairMYoshizawaKKiyosawaK2001Relationship between hepatitis C virus infection and Schistosomal liver disease: not simply an additive effect. J Gastroenterol. 36117538
  16. 16. GhaffarY. AFattahS. AKamelMBadrR. MMahomedF. FStricklandG. T1991The impact of endemic schistosomiasis on acute viral hepatitis. Am J Trop Med Hyg 45743750
  17. 17. A. BGarryR. FDashSGerberMA. 1999Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 606915920
  18. 18. HammadH. AEl-Fattah MMZ, Morris M, Madiner EH, El-Abbasy AA, Soliman AMT1990Study on some hepatic functions and prevalence of hepatitis B surface antigenemia in Egyptian children with schistosomiasis hepatic fibrosis. J Trop Pediat 36126130
  19. 19. Hyams KC Alamy MEPazzaglia G, El-Ghorab NM, Sidom O, Habib M, Dunn MA 1987Risk of hepatitis B infection among Egyptians with Schistosoma mansoni. Am J Trop Med Hyg 3510351039
  20. 20. KamalS. MMadwarM. ABianchinLTawilA. FFawxyRPetersTRasenackJ. W2000aClinical virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with Schistosoma mansoni. Liver 4281289
  21. 21. KamalS. MMadwarM. APetersTFawzyRRasenackJ2000bInterferon therapy in patients with hepatitis C and schistosomiasis. Journal of Hepatology. 32172174
  22. 22. KamelK. CEl-AlamyM. EMillerF. DEl-MasryA. GZakarisSKhattabMEssmatG1994The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 88501509
  23. 23. KatoK1960A correct application of the thick-smear technique with cellophane paper cover. A pamphlet, 9In Komyia Y & Kobayashi A. (eds). Evaluation of Kato thick-smear technique with a cellophane cover for helminth eggs in Feces. Jap J Med Sci Biol 19: 58-64.
  24. 24. KatzNChavesAPellegrinoJ1972A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 4397400
  25. 25. LambertucciJ. RSilva LCS, Voieta I. 2005Esquistossomose Mansônica. In Coura JR. Dinâmica das Doenças Infecciosas e Parasitárias. 1ª edição. Editora Guanabara Koogan, 932946
  26. 26. LarouzeBDazzaM. CGaudeboutCHabibMElamyMClineB1987Absence of relationship between Schistosoma mansoni and hepatitis B virus infection in the Qalyub Governate- Egypt. Ann Trop Med Parasitol 81373375
  27. 27. LutzA1919OSchistosomume a Schistosomatose segundo observações feitas no Brasil. Mem Inst Oswaldo Cruz 11121155
  28. 28. LyraL. DRebouçasGAndradeZ1976Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology 71641647
  29. 29. MadwarM. AEl-TahawyMStricklandG. T1989There was not relationship between uncomplicated schistosomiasis and hepatitis B infection. Trans R Soc Trop Med Hyg 83233236
  30. 30. Pereira LMMBMelo MCV, Lacerda C, Spinelli V, Domingues ALC, Massarolo P, Mies S, Saleh MG, Mcfarlane IG, William R 1994Hepatitis B virus infection in Schistosomiasis mansoni. J Med Virol 42203206
  31. 31. PessoaS. BBarrosP. S1953Notas sobre a Epidemiologia da esquistossomose mansônica no Estado de Sergipe. Rev Med Cir São Paulo 13147154
  32. 32. PrinceA. M1970Prevalence of serum hepatitis related antigen (SH) in different geographic regions. Am J Trop Med Hyg 19: 872.
  33. 33. SerufoJ. C2000Association of Hepatitis B and Schistosomiasis: an ecological fallacy. Rev. Soc. Bras. Med. Trop. 331103104Abstract-PhD Thesis, Universidade Federal de Minas Gerais-UFMG.
  34. 34. SerufoJ. CAntunes CMF, Pinto-Silva RA, Gerspacher-Lara R, Rayes AAM, Drummond SC, Reis CMF, Martins MJ, Mingoti SA, Lambertucci JR. 1998Chronic Carriers of Hepatitis B Surface Antigen in an Endemic Area for Schistosomiasis mansoni in Brazil. Mem. Inst.Oswaldo Cruz 9 (Suppl. I): 249253

Written By

Maria José Conceição and José Rodrigues Coura

Submitted: 08 May 2012 Published: 16 January 2013